(Q42499547)

1 November 2017

title

Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases (English)

1 reference

1 November 2017

0 references

Johan F Schoeman

1

1 reference

1 November 2017

Graham Fieggen

2

1 reference

1 November 2017

Neil Seller

3

1 reference

1 November 2017

Marc Mendelson

4

1 reference

1 November 2017

Bennie Hartzenberg

5

1 reference

1 November 2017

publication date

1 April 2006

1 reference

Journal of Child Neurology

1 November 2017

published in

1 reference

1 November 2017

volume

21

1 reference

1 November 2017

issue

4

1 reference

1 November 2017

page(s)

301-308

1 reference

Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Paradoxical expansion of intracranial tuberculomas during chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Central nervous system tuberculosis: medical management and surgical indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Paradoxical progression of tuberculous lesions during chemotherapy of central nervous system tuberculosis. Report of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Tuberculosis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Tumor necrosis factor-alpha increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F08830738060210040801

10.1177/08830738060210040801

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference